Risk of developing radiogenic cancer following photon‐beam radiotherapy for Graves’ orbitopathy
Sign Up to like & getrecommendations! Published in 2018 at "Medical Physics"
DOI: 10.1002/mp.13130
Abstract: PURPOSE The objective of this study was to estimate the probability for cancer development due to radiotherapy for Graves' orbitopathy with 6 MV x rays. METHODS Orbital irradiation was simulated with the MCNP code. The… read more here.
Keywords: risk; radiotherapy graves; radiotherapy; graves orbitopathy ... See more keywords
Proposing a surgical algorithm for graduated orbital decompression in patients with Graves’ orbitopathy
Sign Up to like & getrecommendations! Published in 2021 at "European Archives of Oto-Rhino-Laryngology"
DOI: 10.1007/s00405-021-07003-0
Abstract: To determine the outcome after orbital decompression using a graduated technique, adapting the surgical technique according to individual patients’ disease characteristics. We retrospectively examined the postoperative outcome in patients treated with a graduated balanced orbital… read more here.
Keywords: decompression; proposing surgical; graves orbitopathy; graduated orbital ... See more keywords
Efficacy of rituximab in patients with Graves’ orbitopathy: a retrospective multicenter nationwide study
Sign Up to like & getrecommendations! Published in 2020 at "Graefe's Archive for Clinical and Experimental Ophthalmology"
DOI: 10.1007/s00417-020-04651-6
Abstract: Purpose The clinical utility of rituximab (RTX) in Graves’ orbitopathy (GO) treatment remains controversial since the discrepant results from 2 prospective randomized studies (Stan M et al. J Clin Endocrinol Metab 2015; Salvi M et… read more here.
Keywords: rituximab; week; treatment; study ... See more keywords
Severe Graves’ Orbitopathy occurring in a patient with thyroid hemiagenesis
Sign Up to like & getrecommendations! Published in 2018 at "Endocrine"
DOI: 10.1007/s12020-018-1662-9
Abstract: A 64-year old woman was addressed to the endocrinology clinics, following the observation of subclinical hypothyroidism and positive anti-TPO auto-antibodies (TSH levels 6.28 uUI/ml). Ultrasound examination (Fig. 1a) showed a diffusely enlarged heterogeneous hypoechoic right… read more here.
Keywords: diplopia; graves orbitopathy; thyroid hemiagenesis; fig ... See more keywords
Teprotumumab: a new avenue for the management of moderate-to-severe and active Graves’ orbitopathy?
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Endocrinological Investigation"
DOI: 10.1007/s40618-017-0717-8
Abstract: discrepancy [8],because of these conflicting results, the role of rituximab for moderate-to-severe and active GO remains to be defined in larger, multicenter RCTs [9]. The recent guidelines published by the European Thyroid Association/ European Group… read more here.
Keywords: graves orbitopathy; moderate severe; receptor; active graves ... See more keywords
Rehabilitative orbital decompression for Graves’ orbitopathy: results of a randomized clinical trial
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Endocrinological Investigation"
DOI: 10.1007/s40618-018-0847-7
Abstract: PurposeOrbital decompression (OD) is a consolidated procedure for the treatment of exophthalmos in Graves’ orbitopathy (GO). The efficacy of the various procedures remains unclear due to the variability of the techniques used. To address this… read more here.
Keywords: decompression; randomized clinical; graves orbitopathy; operative diplopia ... See more keywords
Can combination of glucocorticoids with other immunosoppressive drugs reduce the cumulative dose of glucocorticoids for moderate-to-severe and active Graves’ orbitopathy?
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Endocrinological Investigation"
DOI: 10.1007/s40618-019-01015-8
Abstract: Graves’ orbitopathy (GO) is the main non-thyroidal expression of Graves’ disease [1]. Management of moderate-tosevere and active forms of the disease remains a major and not completely solved therapeutic challenge and dilemma [2]. Glucocorticoids are,… read more here.
Keywords: combination; treatment; cumulative dose; graves orbitopathy ... See more keywords
Occurrence of Graves’ hyperthyroidism and Graves’ orbitopathy after fine-needle aspiration biopsy of thyroid nodules
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Endocrinological Investigation"
DOI: 10.1007/s40618-020-01199-4
Abstract: Graves’ orbitopathy (GO) is believed to reflect an autoimmune aggression against antigens expressed by thyroid epithelial cells and orbital fibroblasts [1]. We report a case of de novo appearance of Graves’ hyperthyroidism (GH) and GO… read more here.
Keywords: graves hyperthyroidism; needle aspiration; graves orbitopathy; fine needle ... See more keywords
Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Endocrinological Investigation"
DOI: 10.1007/s40618-020-01258-w
Abstract: Purpose Patients with Graves’ orbitopathy can present with asymmetric disease. The aim of this study was to identify clinical characteristics that distinguish asymmetric from unilateral and symmetric Graves’ orbitopathy. Methods This was a multi-centre study… read more here.
Keywords: disease; study; graves orbitopathy; severe active ... See more keywords
Changes in ocular biomechanics after treatment for active Graves’ orbitopathy
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Endocrinological Investigation"
DOI: 10.1007/s40618-020-01322-5
Abstract: Purpose To evaluate the changes in ocular biomechanical properties in active moderate-to-severe Graves’ orbitopathy (GO) after intravenous glucocorticoids (IVGCs), and to clarify correlations between clinical findings and ocular biomechanical properties. Methods A prospective study. A… read more here.
Keywords: changes ocular; biomechanical properties; biomechanics; ocular biomechanical ... See more keywords
Graves’ disease and Graves’ orbitopathy following COVID-19
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Endocrinological Investigation"
DOI: 10.1007/s40618-021-01576-7
Abstract: Upon genetic predisposition, Graves’ disease (GD) is believed to be triggered by nongenetic factors, including infections [1]. The immune system plays a role in Coronavirus disease 2019 (COVID-19), being involved in its clinical course and… read more here.
Keywords: following covid; orbitopathy following; covid; graves orbitopathy ... See more keywords